RecruitingNot applicableNCT05825482
Breast Margin Study: Routine Cavity Shave Margins Vs. Selective Margins Using Savi Scout®
Studying STING-associated vasculopathy with onset in infancy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Case Comprehensive Cancer Center
- Principal Investigator
- Andrew Fenton, M.D.Cleveland Clinic Akron General, Case Comprehensive Cancer Center
- Intervention
- Arm 1 Partial mastectomy with Savi Scout® localization and shave margins.(procedure)
- Enrollment
- 204 target
- Eligibility
- 18 years · FEMALE
- Timeline
- 2023 – 2026
Study locations (1)
- Cleveland Clinic Akron General, Case Comprehensive Cancer Center, Akron, Ohio, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05825482 on ClinicalTrials.gov